Can an AI trained on real heart patients outsmart generic chatbots?

NCT ID NCT07766551

First seen Aug 14, 2026 ยท Last updated Aug 14, 2026

Summary

This study aims to build a specialized AI model, called CorAI, for coronary artery disease (CAD). Researchers will collect de-identified medical data from about 640 patients with suspected or confirmed CAD to create a rich dataset. Using this data, they will develop and test CorAI to see if its recommendations align with clinical guidelines, potentially offering a new tool to support doctors' decisions.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
CorAI, a disease-specific large language model (AI) developed and evaluated using patient data
What this could lead to
If successful, this could lead to an AI tool that helps doctors make more guideline-aligned decisions for heart disease patients, potentially improving care quality.
What could go wrong
The AI model is new and untested in real-world settings. It may not perform as expected or may not generalize beyond the study's specific patient group. There is also a risk of AI errors or biases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICAL INTELLIGENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen

    Shenzhen, Guangdong, 518057, China

  • Fuwai Hospital, Chinese Academy of Medical Sciences/National Center for Cardiovascular Diseases

    Beijing, Beijing Municipality, 100037, China

  • The First Affiliated Hospital of USTC

    Hefei, Anhui, 230001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.